KRT7 and neoplasm: have suggested that the evaluation of KRT7 mRNA expression in circulating tumor cells (CTCs) among patients who have been diagnosed with urothelial bladder cancer prior to undergoing radical cystectomy (RC) or bladder removal surgery is a crucial tool for predicting patient prognosis and identifying potential candidates for systemic treatment (19, 20).